Table 1.

Top 10 most highly cited documents in the field of onconephrology between 1 January 2000 and 27 April 2024.

Rank	First author	Publication year	Document title	Journal	Impact factor	Citation number
1	Solano et al.	2006	A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage	J Pain Symptom Manage	4.7	750
2	Launay-Vacher et al.	2007	Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study	Cancer	6.2	338
3	Knudsen et al.	2000	Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group	Eur J Haematol	3.1	312
4	Dimopoulos et al.	2010	Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group	J Clin Oncol	45.3	304
5	Dimopoulos et al.	2016	International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment	J Clin Oncol	45.3	252
6	Volarevic et al.	2019	Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity	J Biomed Sci	11	249
7	Clark et al.	2005	Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial	Ann Intern Med	39.2	244
8	Wanchoo et al.	2017	Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review	Am J Nephrol	4.2	236
9	Dimopoulos et al.	2008	Pathogenesis and treatment of renal failure in multiple myeloma	Leukemia	11.4	221
10	Fudaba et al.	2006	Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses	Am J Transplant	8.8	218